Litcius/Paper detail

mTOR Signaling Components in Tumor Mechanobiology

Antonios N. Gargalionis, Kostas A. Papavassiliou, Efthimia K. Basdra, Athanasios G. Papavassiliou

2022International Journal of Molecular Sciences33 citationsDOIOpen Access PDF

Abstract

Mechanistic target of rapamycin (mTOR) is a central signaling hub that integrates networks of nutrient availability, cellular metabolism, and autophagy in eukaryotic cells. mTOR kinase, along with its upstream regulators and downstream substrates, is upregulated in most human malignancies. At the same time, mechanical forces from the tumor microenvironment and mechanotransduction promote cancer cells' proliferation, motility, and invasion. mTOR signaling pathway has been recently found on the crossroads of mechanoresponsive-induced signaling cascades to regulate cell growth, invasion, and metastasis in cancer cells. In this review, we examine the emerging association of mTOR signaling components with certain protein tools of tumor mechanobiology. Thereby, we highlight novel mechanisms of mechanotransduction, which regulate tumor progression and invasion, as well as mechanisms related to the therapeutic efficacy of antitumor drugs.

Topics & Concepts

MechanobiologyPI3K/AKT/mTOR pathwaySignal transductionCell biologyBiologyChemistryPI3K/AKT/mTOR signaling in cancerHippo pathway signaling and YAP/TAZMelanoma and MAPK Pathways
mTOR Signaling Components in Tumor Mechanobiology | Litcius